Friday, December 8, 2017

Improving Medical Cannabis Programs Will Combat Opioid Crisis

Americans for Safe Access Releases a Blueprint for State Policy

WASHINGTON, DC — Today, Americans for Safe Access released “Medical Cannabis as a Tool to Combat Pain and the Opioid Crisis: A Blueprint for State Policy.” The blueprint outlines legislative and regulatory solutions related to medical cannabis that states can utilize to combat the opioid epidemic.

Medical cannabis is a proven alternative to treat chronic pain. Medical professionals and researchers have released studies demonstrating its positive effects and overall benefits to public health. However, medical cannabis programs are serving just 2 percent of the population in most of the thirty states, Washington, D.C., Puerto Rico and Guam that have so far passed laws (another sixteen have passed more limited laws). One-third of the U.S. population is living with chronic pain, and they all deserve access to medical cannabis. The blueprint lays out the specific barriers to access contributing to this disparity and provides lawmakers with the legislative means to reduce those barriers.

“I am excited to introduce this book to potential bill sponsors in my state,” said Jamie Lowell, a medical cannabis advocate and organizer in Michigan. “Medical cannabis allowed me to wean myself off of opiates, and I’m hopeful that by introducing this model legislation, we can reduce some of the barriers to medical cannabis and help even more Michigan patients.”

The report features model legislation, an emergency proclamation, and flow charts that help lawmakers identify barriers to access that medical cannabis patients in their states are facing. It also highlights the state of Michigan as a case study to illustrate how many individuals are potentially excluded from state medical cannabis programs. Michigan filed emergency regulations December 4th, which will improve product safety standards through testing and security. However, as the state develops legislation to manage the program for the longer term, it should look to the model legislation included in this blueprint to eliminate many of the current barriers to patient access.

“As many state legislatures are currently pre-filing bills for the 2018 legislative session, this report provides a critical toolkit for states to respond to the opioid crisis and be ready in their upcoming sessions to introduce legislation that will not only improve their state cannabis programs, but lower the instances of opioid addiction and overdose deaths. It has been nearly two months since President Trump declared the opioid crisis a public health emergency. However, since this declaration, there has been no effort on the federal level to provide funds for this crisis,” said Steph Sherer, Executive Director of Americans for Safe Access.

“It is clear that states will have to take healthcare outcomes into their own hands. This report gives them the framework and tools they need to make cannabis an option in their fight against the opioid epidemic.”

This report comes on the tail of the President’s Commission on Drug Abuse and Combating the Opioid Crisis report issued on November 1, 2017. The Commission’s report identified over fifty solutions to the crisis, but failed to include the utility of cannabis, even though states with medical cannabis programs have witnessed a 25 percent reduction of opioid overdose deaths. It’s time for every state to enact programs that will provide access to medical cannabis for all chronic pain patients, and the guidelines provided here will help new states and those with existing programs to better respond to the opioid crisis which the Centers for Disease Control have estimated cost 65,000 lives in 2016.

Councilman David Grosso has already introduced parts of the legislation in an effort to reduce opioid overdose deaths in Washington, D.C., and Americans for Safe Access anticipates other programs will welcome the ability to proactively work towards reducing opioid overdose deaths in their states.

Download the Full Report Here:

December 07, 2017 | by Beth Collins

About Beth Collins, Senior Director of Government Relations and External Affairs For Americans For Safe Access:

Beth Collins first became involved in medical cannabis advocacy in 2013 while trying to help treat her daughter Jennifer’s intractable epilepsy. After trying and failing numerous pharmaceutical medications, Beth and Jennifer left her husband and other daughter in Virginia, and moved to Colorado to access cannabis oil to treat Jennifer’s seizures. While in Colorado, Beth began lobbying the Virginia General Assembly for access to medical cannabis. In 2014, Beth and her daughter returned to Virginia and she worked with other parents to pass legislation that allows her daughter to take THCa oil in the state without fear of prosecution. She continues to work with Virginia’s lawmakers to expand access and cultivation in the state.

In addition, Beth helped form and lead the Parents Coalition for Rescheduling Medical Cannabis, a national parent group with the mission of removing cannabis from its current schedule 1 status. She has also lobbied Congress in support of the CARERS Act, the most comprehensive piece of federal medical marijuana legislation ever introduced in both the U.S. House and Senate.

In January 2016, Beth joined the staff of Americans for Safe Access where she hopes to help advocates initiate, expand, and improve state medical cannabis laws and programs, and work with Federal decision makers to reschedule cannabis and reduce the conflict between state and federal cannabis laws.